Di-μ-oxido-bis­[(4-formyl-2-methoxy­phenolato-κO 1)oxido(1,10-phenan­throline-κ2 N,N′)vanadium(V)]

The title complex, [V2(C8H7O3)2O4(C12H8N2)2], is a centrosymmetric dimer formed by two VV complex units bridged by two μ2-oxido groups. The VV atom is six-coordinated by three oxide O atoms, one O atom from a vanillinate ligand and two N atoms from a 1,10-phenanthroline ligand in a significantly distorted octa­hedral geometry. In the crystal structure, weak inter­molecular C—H⋯O hydrogen bonds connect the mol­ecules into a three-dimensional network

(Methoxo-κO)oxidobis(quinolin-8-olato-κ2 N,O)vanadium(V)

In the title complex, [V(C9H6NO)2(CH3O)O], the central VV atom is coordinated by the O atoms from the oxido and methoxo ligands and the N and O atoms of two bis-chelating quinolin-8-olate ligands, forming a distorted octa­hedral environment. In the crystal structure, weak inter­molecular C—H⋯O hydrogen bonds connect mol­ecules into centrosymmetric dimers which are, in turn, linked by weak C—H⋯π inter­actions into chains along the b axis

Experimental upstream transmission of continuous variable quantum key distribution access network

Continuous-variable quantum key distribution which can be implemented using only low-cost and off-the-shelf components reveals great potential in the practical large-scale realization. Access network as a modern network necessity, connects multiple end-users to the network backbone. In this work, we demonstrate the first upstream transmission quantum access networks using continuous-variable quantum key distribution. A two-end-user quantum access network is then experimentally realized. Through phase compensation, data synchronization and other technical upgrades, we achieve 390kbps secret key rate of the total network. In addition, we extend the case of two-end-user quantum access network to the case of multiple users, and analyze the network capacity in the case of multiple users by measuring the additive excess noise from different time slots.Comment: 4 pages,3figure

{N-[(2-Oxido-1-naphth­yl)methyl­idene]­serinato-κ3 O,N,O′}(1,10-phenanthroline-κ2 N,N′)copper(II)

In the title complex, [Cu(C14H11NO4)(C12H8N2)], the tridentate Schiff base ligand is derived from the condensation of 2-hydr­oxy-1-naphthaldehyde and l-serine. The CuII atom is five-coordinated by one N atom and two O atoms from the Schiff base ligand and by two N atoms from a 1,10-phenanthroline ligand in a distorted square-pyramidal geometry. In the crystal structure, the combination of inter­molecular O—H⋯O and C—H⋯O hydrogen bonds results in a two-dimensional network structure parallel to (001)

Bis[μ-N-(3-meth­oxy-2-oxidobenzyl­idene-1:2κ2 O 2:O 2)-l-isoleucinato-2κ2 N,O]bis­(1,10-phenanthroline-1κ2 N,N′)dinickel(II) methanol tetra­solvate trihydrate

In the title complex, [Ni2(C14H17NO4)2(C12H8N2)2]·4CH3OH·3H2O, the two NiII ions are bridged by two Schiff base anions, leading to a dinuclear complex. One NiII ion is six-coordinated by four O atoms and two N atoms of two tridentate Schiff base ligands derived from the condensation of l-isoleucine and o-vanillin. The other NiII ion is six-coordinated by four N atoms of two 1,10-phenanthroline ligands and two O atoms of the Schiff base ligands. In the crystal, inter­molecular O—H⋯O and C—H⋯O hydrogen bonds lead to a three-dimensional structure. Intra­molecular C—H⋯O hydrogen bonds are also present. One of the methyl groups of the l-isoleucinate moieties is disordered over two sets of sites with an occupancy ratio of 0.687 (19):0.313 (19) and two methanol mol­ecules are half-occupied

Derivation of Rhesus Monkey Parthenogenetic Embryonic Stem Cells and Its MicroRNA Signature

Parthenogenetic embryonic stem cells are considered as a promising resource for regeneration medicine and powerful tools for developmental biology. A lot of studies have revealed that embryonic stem cells have distinct microRNA expression pattern and these microRNAs play important roles in self-renewal and pluripotency of embryonic stem cells. However, few studies concern about microRNA expression pattern in parthenogenetic embryonic stem cells, especially in non-human primate—the ideal model species for human, largely due to the limited rhesus monkey parthenogenetic embryonic stem cells (rpESCs) available and lack of systematic analysis of the basics of rpESCs. Here, we derived two novel rpESCs lines and characterized their microRNA signature by Solexa deep sequencing. These two novel rpESCs shared many properties with other primate ESCs, including expression of pluripotent markers, capacity to generate derivatives representative of all three germ layers in vivo and in vitro, maintaining of euploid karyotype even after long culture. Additionally, lack of some paternally expressed imprinted genes and identity of Single-nucleotide Polymorphism (SNP) compare to their oocyte donors support their parthenogenesis origin. By characterizing their microRNA signature, we identified 91 novel microRNAs, except those are also detected in other primate ESCs. Moreover, these two novel rpESCs display a unique microRNA signature, comparing to their biparental counterpart ESCs. Then we analyzed X chromosome status in these two novel rpESCs; results suggested that one of them possesses two active X chromosomes, the other possesses only one active X chromosome liking biparental female embryonic stem cells. Taken together, our novel rpESCs provide a new alternative to existing rhesus monkey embryonic stem cells, microRNA information expands rhesus monkey microRNA data and may help understanding microRNA roles in pluripotency and parthenogenesis

Case report: Unveiling the unforeseen: a catastrophic encounter of giant aortic aneurysm rupture during re-sternotomy in a patient with bicuspid aortic valve and previous surgical aortic valve replacement

Due to structural abnormalities in the leaflets, patients with bicuspid aortic valve (BAV) may develop isolated aortic valve disease, such as aortic regurgitation, aortic stenosis, or a combination of both. In addition to valvular pathology, numerous studies have indicated that approximately 40% of BAV patients exhibit aortic pathologies characterized by aortic dilatation. According to guidelines for valvular diseases, patients with BAV who require surgical aortic valve replacement (SAVR) and have a diameter of the aortic sinuses or ascending aorta ≥4.5 cm are recommended to undergo concomitant replacement of the aortic sinuses or ascending aorta. However, we encountered a case in 2020 involving a patient with severe aortic regurgitation due to BAV and an ascending aortic diameter of 4.2 cm. This patient underwent SAVR and ascending aortoplasty surgery at our center. Remarkably, three years postoperatively, the patient's aortic diameter rapidly expanded by nearly threefold, which also suggests the risk of encountering a giant aortic root aneurysm during reoperation. Unfortunately, a fatal rupture of a giant aortic root aneurysm was encountered during re-sternotomy. Fortunately, with adequate preoperative planning, we successfully managed to avert this perilous situation. The patient recovered without complications and was discharged on the 8th day. Individualized surgical plans were formulated based on a comprehensive evaluation of the perioperative conditions

Antifungal effects and biocontrol potential of lipopeptide-producing Streptomyces against banana Fusarium wilt fungus Fusarium oxysporum f. sp. cubense

Fusarium wilt of banana (FWB), caused by Fusarium oxysporum f. sp. cubense (Foc), especially tropical race 4 (TR4), presents the foremost menace to the global banana production. Extensive efforts have been made to search for efficient biological control agents for disease management. Our previous study showed that Streptomyces sp. XY006 exhibited a strong inhibitory activity against several phytopathogenic fungi, including F. oxysporum. Here, the corresponding antifungal metabolites were purified and determined to be two cyclic lipopeptide homologs, lipopeptin A and lipopeptin B. Combined treatment with lipopeptin complex antagonized Foc TR4 by inhibiting mycelial growth and conidial sporulation, suppressing the synthesis of ergosterol and fatty acids and lowering the production of fusaric acid. Electron microscopy observation showed that lipopeptide treatment induced a severe disruption of the plasma membrane, leading to cell leakage. Lipopeptin A displayed a more pronounced antifungal activity against Foc TR4 than lipopeptin B. In pot experiments, strain XY006 successfully colonized banana plantlets and suppressed the incidence of FWB, with a biocontrol efficacy of up to 87.7%. Additionally, XY006 fermentation culture application improved plant growth parameters and induced peroxidase activity in treated plantlets, suggesting a possible role in induced resistance. Our findings highlight the potential of strain XY006 as a biological agent for FWB, and further research is needed to enhance its efficacy and mode of action in planta